Literature DB >> 33357518

Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.

Nicholas G Davies1, Rosanna C Barnard2, Christopher I Jarvis2, Timothy W Russell2, Malcolm G Semple3, Mark Jit2, W John Edmunds2.   

Abstract

BACKGROUND: A second wave of COVID-19 cases in autumn, 2020, in England led to localised, tiered restrictions (so-called alert levels) and, subsequently, a second national lockdown. We examined the impact of these tiered restrictions, and alternatives for lockdown stringency, timing, and duration, on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and hospital admissions and deaths from COVID-19.
METHODS: We fit an age-structured mathematical model of SARS-CoV-2 transmission to data on hospital admissions and hospital bed occupancy (ISARIC4C/COVID-19 Clinical Information Network, National Health Service [NHS] England), seroprevalence (Office for National Statistics, UK Biobank, REACT-2 study), virology (REACT-1 study), and deaths (Public Health England) across the seven NHS England regions from March 1, to Oct 13, 2020. We analysed mobility (Google Community Mobility) and social contact (CoMix study) data to estimate the effect of tiered restrictions implemented in England, and of lockdowns implemented in Northern Ireland and Wales, in October, 2020, and projected epidemiological scenarios for England up to March 31, 2021.
FINDINGS: We estimated a reduction in the effective reproduction number (Rt) of 2% (95% credible interval [CrI] 0-4) for tier 2, 10% (6-14) for tier 3, 35% (30-41) for a Northern Ireland-stringency lockdown with schools closed, and 44% (37-49) for a Wales-stringency lockdown with schools closed. From Oct 1, 2020, to March 31, 2021, a projected COVID-19 epidemic without tiered restrictions or lockdown results in 280 000 (95% projection interval 274 000-287 000) hospital admissions and 58 500 (55 800-61 100) deaths. Tiered restrictions would reduce hospital admissions to 238 000 (231 000-245 000) and deaths to 48 600 (46 400-50 700). From Nov 5, 2020, a 4-week Wales-type lockdown with schools remaining open-similar to the lockdown measures announced in England in November, 2020-was projected to further reduce hospital admissions to 186 000 (179 000-193 000) and deaths to 36 800 (34 900-38 800). Closing schools was projected to further reduce hospital admissions to 157 000 (152 000-163 000) and deaths to 30 300 (29 000-31 900). A projected lockdown of greater than 4 weeks would reduce deaths but would bring diminishing returns in reducing peak pressure on hospital services. An earlier lockdown would have reduced deaths and hospitalisations in the short term, but would lead to a faster resurgence in cases after January, 2021. In a post-hoc analysis, we estimated that the second lockdown in England (Nov 5-Dec 2) reduced Rt by 22% (95% CrI 15-29), rather than the 32% (25-39) reduction estimated for a Wales-stringency lockdown with schools open.
INTERPRETATION: Lockdown measures outperform less stringent restrictions in reducing cumulative deaths. We projected that the lockdown policy announced to commence in England on Nov 5, with a similar stringency to the lockdown adopted in Wales, would reduce pressure on the health service and would be well timed to suppress deaths over the winter period, while allowing schools to remain open. Following completion of the analysis, we analysed new data from November, 2020, and found that despite similarities in policy, the second lockdown in England had a smaller impact on behaviour than did the second lockdown in Wales, resulting in more deaths and hospitalisations than we originally projected when focusing on a Wales-stringency scenario for the lockdown. FUNDING: Horizon 2020, UK Medical Research Council, and the National Institute for Health Research.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33357518      PMCID: PMC7758181          DOI: 10.1016/S1473-3099(20)30984-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  37 in total

1.  FAIR data pipeline: provenance-driven data management for traceable scientific workflows.

Authors:  Sonia Natalie Mitchell; Andrew Lahiff; Nathan Cummings; Jonathan Hollocombe; Bram Boskamp; Ryan Field; Dennis Reddyhoff; Kristian Zarebski; Antony Wilson; Bruno Viola; Martin Burke; Blair Archibald; Paul Bessell; Richard Blackwell; Lisa A Boden; Alys Brett; Sam Brett; Ruth Dundas; Jessica Enright; Alejandra N Gonzalez-Beltran; Claire Harris; Ian Hinder; Christopher David Hughes; Martin Knight; Vino Mano; Ciaran McMonagle; Dominic Mellor; Sibylle Mohr; Glenn Marion; Louise Matthews; Iain J McKendrick; Christopher Mark Pooley; Thibaud Porphyre; Aaron Reeves; Edward Townsend; Robert Turner; Jeremy Walton; Richard Reeve
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2022-08-15       Impact factor: 4.019

2.  Drivers of Household Recycling Behavior in the City of Johannesburg, South Africa.

Authors:  Dorothea Christina Schoeman; Isaac Tebogo Rampedi
Journal:  Int J Environ Res Public Health       Date:  2022-05-20       Impact factor: 4.614

3.  Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study.

Authors:  Ana Rita Torres; Ana Paula Rodrigues; Mafalda Sousa-Uva; Irina Kislaya; Susana Silva; Liliana Antunes; Carlos Dias; Baltazar Nunes
Journal:  Euro Surveill       Date:  2022-06

4.  Mental Well-Being and Sexual Intimacy among Men and Gender Diverse People Who Have Sex with Men during the First UK COVID-19 Lockdown: A Mixed-Methods Study.

Authors:  Natalie L Edelman; T Charles Witzel; Phil Samba; Will Nutland; Tom Nadarzynski
Journal:  Int J Environ Res Public Health       Date:  2022-06-07       Impact factor: 4.614

5.  Vaccination and Government Stringent Control as Effective Strategies in Preventing SARS-CoV-2 Infections: A Global Perspective.

Authors:  Peng Yang; Zhe Yang; Chenxi Zhao; Xinrui Li; Zhongjun Shao; Kun Liu; Lei Shang
Journal:  Front Public Health       Date:  2022-06-24

6.  The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival.

Authors:  L Ponoop Prasad Patro; Chakkarai Sathyaseelan; Patil Pranita Uttamrao; Thenmalarchelvi Rathinavelan
Journal:  Comput Struct Biotechnol J       Date:  2021-06-05       Impact factor: 7.271

Review 7.  COVID-19: Current knowledge in clinical features, immunological responses, and vaccine development.

Authors:  Ramandeep Singh; Alisha Kang; Xiangqian Luo; Mangalakumari Jeyanathan; Amy Gillgrass; Sam Afkhami; Zhou Xing
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.834

8.  Covid-19: Regional policies and local infection risk: Evidence from Italy with a modelling study.

Authors:  Gabriele Guaitoli; Roberto Pancrazi
Journal:  Lancet Reg Health Eur       Date:  2021-07-15

9.  Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors.

Authors:  Lisa Weidner; Verena Nunhofer; Christof Jungbauer; Alexandra Domnica Hoeggerl; Lydia Grüner; Christoph Grabmer; Georg Zimmermann; Eva Rohde; Sandra Laner-Plamberger
Journal:  Infection       Date:  2021-06-16       Impact factor: 3.553

10.  Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region.

Authors:  Yang Liu; Frank G Sandmann; Rosanna C Barnard; Carl A B Pearson; Roberta Pastore; Richard Pebody; Stefan Flasche; Mark Jit
Journal:  medRxiv       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.